Perioperative Risk, Anesthesia, Critical Care, and Readmissions

10.1Guidance frame and preoperative risk inputs

Perioperative planning in vascular surgery is not “clearance”; it is a structured estimate of cardiac, pulmonary, renal, bleeding, functional, and recovery risk that should change the operative plan when risk is modifiable and sharpen consent when it is not. Major vascular operations should generally be treated as elevated-risk procedures, so the default for elective open aortic repair, infrainguinal bypass, and complex revascularization is formal risk stratification rather than a perfunctory preoperative note. Contemporary AHA/ACC guidance supports a stepwise approach using validated clinical indices, functional capacity expressed in metabolic equivalents, and selective biomarkers or stress imaging when the result would change management. Evidence source 2024

The Revised Cardiac Risk Index remains a useful bedside checklist because its six variables map to common vascular patients: high-risk surgery, ischemic heart disease, heart failure, cerebrovascular disease, insulin-treated diabetes, and creatinine above 2.0 mg/dL. Derivation prospective validation 1999 Its limitations are equally important: it was derived before modern high-sensitivity troponin and natriuretic peptide strategies, and it should not be the sole risk language for a frail patient with poor reserve or a complex vascular reconstruction. Vascular-specific models occupy the same clinical space but may better reflect the risk profile of carotid endarterectomy, lower-extremity bypass, EVAR, and open AAA repair. Vascular Study Group 2010

Functional capacity should be elicited deliberately because vague statements such as “active for age” are often misleading. The practical question is whether the patient can perform meaningful exertion without angina, dyspnea, presyncope, or exhaustion, and whether the history is reliable enough to guide testing. ESC guidance similarly emphasizes metabolic-equivalent assessment, clinical risk scoring, and targeted use of natriuretic peptides or stress imaging in patients with poor functional capacity and elevated clinical risk before high-risk elective surgery. Contemporary cohort evidence comparing subjective capacity, Duke Activity Status Index, cardiopulmonary exercise testing, and NT-proBNP supports treating functional capacity as a measured risk input rather than a casual impression. Evidence source 2022 · Assessment functional capacity 2018

Choice of anesthetic technique should be patient- and procedure-specific rather than ideological. In carotid endarterectomy, the GALA randomized trial found similar 30-day stroke, myocardial infarction, or death rates with general and local anesthesia, supporting operational equipoise when the team is experienced with both approaches. General anaesthesia 2008 The practical conclusion is that carotid anesthesia should be selected around airway risk, contralateral occlusion or monitoring concerns, patient cooperation, surgeon and anesthetist expertise, and the center’s ability to rescue hemodynamic or neurologic deterioration.

Enhanced-recovery pathways provide the organizational frame once the operation is selected. For open aortic surgery, vascular-specific ERAS recommendations span preadmission screening and prehabilitation, carbohydrate loading, venous thromboembolism prophylaxis, anesthetic and epidural protocols, temperature management, multimodal opioid-sparing analgesia, early oral intake and mobilization, and structured fluid and drain management. Perioperative care open 2022 For infrainguinal bypass, ERAS guidance similarly emphasizes prehabilitation, nutrition, multimodal analgesia, mobilization, and discharge planning. Framework perioperative care 2023 These pathways should be adapted locally, because much of the vascular evidence remains moderate or weak rather than trial-definitive.

10.2Frailty and medication decisions

Frailty should be assessed before elective vascular intervention because it predicts outcomes that conventional cardiac indices do not capture well: complications, prolonged length of stay, readmission, mortality, loss of independence, and the need for more intensive discharge planning. In older surgical patients, validated frailty instruments consistently identify patients at higher postoperative risk even when chronological age and operation type appear similar. Preoperative frailty postoperative 2024 · Frailty post-operative outcomes 2016 Frailty should not be used as a single yes-or-no gate; it should trigger a different conversation about goals, alternatives, prehabilitation, postoperative destination, and the likely burden of recovery.

Frailty is especially relevant in vascular surgery because the “successful” technical endpoint may not equal a successful patient-centered outcome. Vascular registry work supports structured frailty assessment at the time of procedure planning for both open and endovascular arterial reconstruction, with frailty independently associated with postdischarge mortality. VQI 2022 Decision-making reviews in frail vascular patients emphasize that elective aortic and lower-extremity revascularization require shared decision-making when standard risk tools underestimate functional decline, institutionalization, or late mortality. Decision making frail 2024

Perioperative beta-blockade is a continuation decision more often than an initiation decision. Established beta-blocker therapy should generally be continued, but starting a new beta-blocker solely because a vascular operation is planned is not supported as a routine maneuver. The POISE trial showed fewer myocardial infarctions with high-dose extended-release metoprolol begun shortly before surgery, but this benefit came with more stroke and higher total mortality. Effects extended-release metoprolol 2008 Systematic review evidence similarly supports caution: potential reductions in myocardial infarction and atrial fibrillation must be weighed against bradycardia and hypotension. Evidence source 2024 · Perioperative beta-blockers preventing 2019

ACE inhibitors and ARBs require individualized handling, particularly in patients vulnerable to vasoplegia, renal hypoperfusion, or difficult clamp-related hemodynamics. A randomized comparison of continuing versus withholding renin-angiotensin system inhibitors before major noncardiac surgery found less intraoperative hypotension when the drug was withheld without more major postoperative cardiovascular or kidney events, supporting a selective hold in hypotension-prone patients. Continuation vs Discontinuation 2024 A separate randomized trial found no statistically significant difference in a composite of intraoperative hypotension or postoperative cardiovascular events between discontinuation and continuation, so the decision should consider the indication for the drug, heart-failure stability, refractory hypertension, and the expected hemodynamic profile of the operation. Discontinuation vs. continuation 2024

Antithrombotic management should match the drug, renal function, bleeding risk of the procedure, and thromboembolic indication. For direct oral anticoagulants, a prospective standardized perioperative protocol based on DOAC pharmacokinetics, procedural bleeding risk, and creatinine clearance—without routine heparin bridging or coagulation-function testing—achieved low 30-day major-bleeding and arterial-thromboembolism rates in atrial-fibrillation patients. DOAC 2019 Consensus synthesis likewise distinguishes warfarin from DOAC interruption schedules and emphasizes that routine bridging has a limited role in many procedural strata. Peri-Procedural Management Oral 2018

10.3Hemodynamics, critical care, and postoperative outcome tracking

Intraoperative hypotension is not a single number; it is a duration, depth, and patient-reserve problem. Patients with chronic hypertension, renal dysfunction, cerebrovascular disease, or marginal coronary reserve may tolerate hypotension poorly even when the absolute mean arterial pressure appears acceptable. Evidence from major noncardiac surgery supports individualized MAP targets, continuous arterial pressure monitoring, vasopressor titration protocols, and goal-directed fluid therapy to reduce the incidence and cumulative duration of hypotension, with the target adapted to baseline pressure, end-organ reserve, and procedural physiology. Intraoperative Hypotension Patients 2025

Postoperative level of care should be selected deliberately rather than assigned by habit. A blanket ICU-for-all policy after vascular surgery is not consistently supported by trial evidence; triage should account for baseline risk, procedural complexity, intraoperative instability, blood loss, vasopressor requirement, respiratory status, renal reserve, and the capacity of the ward or step-down unit to detect early deterioration. Intensive care after 2025 Selective ICU triage is safest when the institution has explicit escalation pathways, reliable monitoring, and a unit capable of managing vascular-specific complications.

Troponin surveillance changes postoperative diagnosis because most perioperative myocardial injury is silent. In a large noncardiac-surgery cohort, high-sensitivity troponin T elevation after surgery was strongly graded with 30-day mortality, and most patients with myocardial injury had no ischemic symptoms. Association Postoperative High-Sensitivity 2017 A separate cohort found troponin elevation above the 99th percentile in about 16% of adults aged 45 years or older after inpatient noncardiac surgery, with nearly 90% of MINS events asymptomatic and independently associated with increased 30-day mortality. Perioperative Myocardial Injury 2018 The bedside implication is simple: absence of chest pain does not exclude clinically important myocardial injury after major vascular surgery.

For vascular patients, postoperative troponin elevation should trigger structured evaluation rather than reflexive dismissal as “demand.” Meta-analysis in vascular surgery found that postoperative troponin elevation predicted short-term mortality, major adverse cardiac events, and long-term mortality. Systematic review meta-analysis 2020 Vascular cohort data further suggest that both ischemic and non-ischemic mechanisms matter prognostically, with ischemic mechanisms carrying the greatest excess late-mortality risk. Associations Between Cardiac 2017 Management should integrate bleeding risk, renal function, graft or wound status, ECG findings, symptoms, hemodynamics, and cardiology input when the result will alter treatment.

The treatment pathway after MINS is evolving. The MANAGE trial found that dabigatran 110 mg twice daily reduced major vascular complications at two years in patients with myocardial injury after noncardiac surgery without a significant increase in major bleeding, but this does not mean every fresh vascular wound should be anticoagulated. Dabigatran patients myocardial 2018 The surgeon’s role is to define the bleeding hazard: fresh anastomosis, neuraxial catheter status, retroperitoneal or groin hematoma, renal function, need for reoperation, and competing antiplatelet requirements must be reconciled before adding anticoagulation.

Delirium, postoperative atrial fibrillation, stroke, and bleeding should be tracked as vascular outcomes, not incidental medical events. An individual-patient-data meta-analysis across noncardiac surgery found postoperative delirium in roughly one in five patients, with older age, baseline cognitive impairment, elevated inflammatory markers, and prolonged anesthetic duration among the strongest predictors. Perioperative Factors Associated 2023 A large international cohort found postoperative atrial fibrillation in about 1% of noncardiac-surgery patients without baseline atrial fibrillation, with NT-proBNP adding independent predictive information. Preoperative levels natriuretic 2020 Perioperative ischemic stroke in cardiac and vascular surgery populations carries elevated cardiovascular and neurologic cause-specific mortality, and pharmacologic bleeding-reduction strategies in vascular surgery may reduce transfusion requirements, although mortality evidence remains low-certainty. Drugs reduce bleeding 2023 · Cause-Specific Mortality 2021

10.4Clinical integration, follow-up, and evidence boundaries

Readmission prevention begins before discharge, not after the patient reappears in the emergency department. In lower-extremity bypass, 30-day readmission is common: ACS-NSQIP data showed an 18% rate, and an institutional cohort showed a 14% rate. Risk factors readmission 2014 Wound infection accounted for a large share of readmission indications, and most readmissions were related and unplanned. Patients returning to the operating room during the index admission, those with cardiac comorbidity, critical-limb-ischemia indication, dialysis dependence, malnutrition, dependent functional status, obesity, or dyspnea require more deliberate discharge planning and earlier contact.

The discharge plan should be tailored to the failure modes of the operation. After lower-extremity bypass, groin wound infection, graft surveillance needs, edema, anticoagulant or antiplatelet transitions, pain control, and mobility limitations are predictable readmission drivers. After open AAA repair, approach-specific signals matter: registry data comparing transabdominal and retroperitoneal open AAA repair reported higher long-term reintervention and 30-day readmission after the transabdominal approach with comparable perioperative mortality, supporting more vigilant postoperative planning when the exposure or recovery burden is higher. AAA 2019 · Risk factors readmission 2014

Early outpatient follow-up is a modifiable care process. Cohort evidence in general and vascular surgery found that earlier post-discharge outpatient follow-up was associated with lower 30-day readmission, and vascular readmission analyses suggest that a meaningful minority of readmissions may be avoidable through index-admission optimization, transitional-care escalation, or earlier clinic review. Avoidable day readmissions 2019 · Outpatient follow-up 2014 For high-risk bypass, open aortic, dialysis, frail, malnourished, or wound-compromised patients, follow-up should be treated as part of the operation’s risk-control plan rather than a routine scheduling task.

Fragmentation of care is itself a vascular risk. Complex aortic patients who travel farther from the index hospital have higher non-index readmission rates, which can hide the true readmission burden from a single-center quality dashboard. Longer patient travel 2023 Before discharge, the team should identify who will evaluate fever, wound drainage, limb symptoms, anticoagulation questions, renal dysfunction, and pain; the patient should not be left to decide whether to call the index vascular team, a local hospital, or a primary-care clinician during the first unstable postoperative weeks.

The evidence base should be used with humility. ERAS pathways for open aortic surgery and lower-extremity bypass organize care well, but many recommendations rest on moderate or weak certainty because vascular-specific randomized trials are limited. Troponin surveillance, ICU triage, frailty scoring, and readmission reduction all require local calibration: assay thresholds, ward capability, rehabilitation access, home support, and travel distance change how published estimates translate to a given patient. Troponin T monitoring 2018 The senior trainee should learn to convert these data into explicit perioperative commitments: what risk is being measured, what will be changed because of the result, who owns the abnormal finding, and when the patient will be reassessed. Framework perioperative care 2023 · Perioperative care open 2022 · Intensive care after 2025